Posts

Germany pushes through healthcare reform package despite pharma's drug discount resistance

on

EU investigates Sanofi over alleged smear campaign against rival flu vaccine Fluad

on

U.S. Launches Section 301 Investigation into Germany Over Drug Pricing and Unfair R&D Burden in 2026

on

Moderna Eyes German Vaccine Facilities as Senate Democrats Push Broad Drug Pricing Reforms

on

Germany’s Health‑Spending Cuts Prompt Lilly and Boehringer to Scale Back German Investments

on

Daiichi Sankyo's ADC Manufacturing Investments and Market Position

on

BioNTech Shuts Down COVID Vaccine Production, Closing Sites and Cutting 1,860 Jobs

on

Novartis to Cut 220 Jobs as Wehr, Germany Site Closes by 2028

on

Novartis Expands Radioligand Therapy Manufacturing with New German Facility

on

German Court Blocks Merck's Subcutaneous Keytruda Over Patent Dispute with Halozyme

on

BioNTech to Acquire CureVac in $1.25B All-Stock mRNA Deal

on